Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,46 USD | +1,49% | -5,37% | +27,57% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 58,65 mln. 54,7 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,45 mln. | Nettowinst (verlies) 2025 * | -28 mln. -26,12 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-2,69
x | K/w-verhouding 2025 * |
-2,9
x | Werknemers | 21 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 84,94% |
Recentste transcriptie over Lantern Pharma Inc.
1 dag | +1,49% | ||
1 week | -5,37% | ||
Lopende maand | -37,95% | ||
1 maand | -44,96% | ||
3 maanden | +30,31% | ||
6 maanden | +92,93% | ||
Lopend jaar | +27,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 01-07-18 |
David Margrave
DFI | Director of Finance/CFO | 64 | 01-06-18 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 02-03-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 01-07-18 |
Director/Board Member | 73 | 08-06-22 | |
Donald Keyser
CHM | Chairman | 71 | 01-01-18 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 5,46 | +1,49% | 124 190 |
24-04-24 | 5,38 | -6,76% | 97 934 |
23-04-24 | 5,77 | +0,87% | 127 436 |
22-04-24 | 5,72 | +7,12% | 255 410 |
19-04-24 | 5,34 | -7,45% | 237 791 |
uitgestelde koers Nasdaq, 25 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,57% | 58,65 mln. | |
+1,12% | 42,59 mld. | |
+6,77% | 40,65 mld. | |
+45,26% | 40,57 mld. | |
-11,96% | 26,77 mld. | |
+6,01% | 24,81 mld. | |
-24,92% | 18,17 mld. | |
-3,63% | 11,7 mld. | |
+27,16% | 12,05 mld. | |
+7,30% | 11,1 mld. |